Non-dilutive funding lets a startup extend its runway without selling ownership, but the three most common mechanisms—government grants, venture debt, and revenue-based financing—serve very different companies. The short answer: pre-revenue R&D-heavy startups are largely limited to grants, venture debt is built for companies that have already raised an equity round, and revenue-based financing suits businesses with consistent, predictable revenue such as SaaS subscriptions. Matching the instrument to your stage and revenue profile is the whole decision.

Government Grants: Fueling Innovation Without Repayment

Grants are the purest form of non-dilutive capital: money from government programs, foundations, or corporations with no repayment required. In the United States, the Small Business Innovation Research and Small Business Technology Transfer programs provide federal funding for science and technology advancement without taking equity, as Stripe's funding guide explains.

The catch is eligibility and process. Grants carry competitive applications, narrow eligibility criteria, and long wait times, and they are often restricted to specific use cases, with reporting rules attached. A guide from Ramp notes that many non-dilutive options require proven revenue, strong credit, or a specific industry focus—and that a pre-revenue startup with no track record may not qualify for loans or revenue-based financing, leaving grants and competitions as the realistic path.

Grants also tend to be smaller than equity rounds. If you need tens of millions to scale quickly, a combination of funding types or a dedicated equity raise may be more realistic than non-dilutive funding alone.